Samsung Bioepis and Organon Expand PYZCHIVA Rights in Canada
INCHEON, South Korea & KIRKLAND, Quebec, Canada, June 18, 2026 Samsung Bioepis and Organon have expanded their long-standing biosimilar...
Dermatology
Advertisement
Skin Tech Pharma Group Wins Best Injectable at AMWC 2026
BARCELONA, Spain, June 17, 2026 Skin Tech Pharma Group has announced that its flagship injectable treatment, RRS® HA LONG...
Quoin Advances QRX003 Development with Positive Pediatric Netherton Syndrome Update
ASHBURN, Va., June 16, 2026 Quoin Pharmaceuticals announced a positive clinical update from its ongoing pediatric Netherton Syndrome (NS)...
Roche’s Tecentriq Receives FDA Priority Review for Stage III Colon Cancer
BASEL, Switzerland, June 11, 2026 Roche has announced that the U.S. Food and Drug Administration (FDA) has granted Priority...
DKSH and BridgeBio Partner to Expand ATTR-CM Treatment Access
SINGAPORE, June 11, 2026 DKSH Healthcare and BridgeBio have entered into a strategic distribution and commercialization partnership aimed at...
Advertisements
Takeda’s Zasocitinib Outperforms Deucravacitinib in Psoriasis
STOCKHOLM, Sweden, June 11OSAKA, Japan and CAMBRIDGE, Massachusetts, June 11, 2026, 2026 Takeda has announced positive topline results from...
FDA Approves New Sunscreen Ingredient After Two Decades
WASHINGTON, D.C., United States, June 9, 2026 The U.S. Food and Drug Administration (FDA) has approved the addition of...
Lilly’s EBGLYSS Wins FDA Approval for Reduced Injection Schedule
INDIANAPOLIS, United States, June 9, 2026 Eli Lilly and Company has secured U.S. Food and Drug Administration (FDA) approval...
PCA SKIN Launches Triple Exfoliation Peel Pads for Home Use
SCOTTSDALE, Ariz., June 1, 2026 PCA SKIN®, a globally recognized leader in professional skincare and chemical peel innovation, has...
Vanda Gains Japan Orphan Status for Imsidolimab
WASHINGTON, May 27, 2026 Vanda Pharmaceuticals Inc. has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has...
Advertisement
